07:00 , Jun 4, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Infectious disease

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Infectious disease Infectious disease Caenorhabditis elegans abnormal dauer formation (DAF-12) In vitro studies suggest that DAF-12 ligands could help treat parasite infections....